You can:
Name | Gastrin-releasing peptide receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | GRPR |
Synonym | GRP-R GRP-preferring bombesin receptor gastrin-releasing peptide receptor BB2 receptor BB2 |
Disease | Solid tumours Breast cancer Cancer Irritable bowel syndrome |
Length | 384 |
Amino acid sequence | MALNDCFLLNLEVDHFMHCNISSHSADLPVNDDWSHPGILYVIPAVYGVIILIGLIGNITLIKIFCTVKSMRNVPNLFISSLALGDLLLLITCAPVDASRYLADRWLFGRIGCKLIPFIQLTSVGVSVFTLTALSADRYKAIVRPMDIQASHALMKICLKAAFIWIISMLLAIPEAVFSDLHPFHEESTNQTFISCAPYPHSNELHPKIHSMASFLVFYVIPLSIISVYYYFIAKNLIQSAYNLPVEGNIHVKKQIESRKRLAKTVLVFVGLFAFCWLPNHVIYLYRSYHYSEVDTSMLHFVTSICARLLAFTNSCVNPFALYLLSKSFRKQFNTQLLCCQPGLIIRSHSTGRSTTCMTSLKSTNPSVATFSLINGNICHERYV |
UniProt | P30550 |
Protein Data Bank | N/A |
GPCR-HGmod model | P30550 |
3D structure model | This predicted structure model is from GPCR-EXP P30550. |
BioLiP | N/A |
Therapeutic Target Database | T99816 |
ChEMBL | CHEMBL4959 |
IUPHAR | 39 |
DrugBank | N/A |
Name | CHEMBL3894546 |
---|---|
Molecular formula | C87H115N19O18S |
IUPAC name | 2-[4-[2-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxo-3-(4-phenylphenyl)propan-2-yl]amino]-3-naphthalen-1-yl-1-oxopropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid |
Molecular weight | 1747.05 |
Hydrogen bond acceptor | 24 |
Hydrogen bond donor | 17 |
XlogP | -2.6 |
Synonyms | N/A |
Inchi Key | INUKFXRWNDKECM-VIFSQCHLSA-N |
Inchi ID | InChI=1S/C87H115N19O18S/c1-52(2)39-67(83(120)97-65(79(89)116)29-38-125-6)99-86(123)71(43-61-45-90-51-93-61)95-73(108)46-92-87(124)78(53(3)4)102-80(117)54(5)94-82(119)70(42-60-44-91-64-22-13-12-21-63(60)64)101-81(118)66(27-28-72(88)107)98-84(121)68(40-55-23-25-57(26-24-55)56-15-8-7-9-16-56)100-85(122)69(41-59-19-14-18-58-17-10-11-20-62(58)59)96-74(109)47-103-30-32-104(48-75(110)111)34-36-106(50-77(114)115)37-35-105(33-31-103)49-76(112)113/h7-26,44-45,51-54,65-71,78,91H,27-43,46-50H2,1-6H3,(H2,88,107)(H2,89,116)(H,90,93)(H,92,124)(H,94,119)(H,95,108)(H,96,109)(H,97,120)(H,98,121)(H,99,123)(H,100,122)(H,101,118)(H,102,117)(H,110,111)(H,112,113)(H,114,115)/t54-,65-,66-,67-,68-,69-,70-,71-,78-/m0/s1 |
PubChem CID | 134136584 |
ChEMBL | CHEMBL3894546 |
IUPHAR | N/A |
BindingDB | N/A |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
IC50 | 30.0 nM | None | ChEMBL |
zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218